Imaging system for screening and diagnosis of breast cancer

Abstract

This invention provides a non-invasive diagnosis system that is not only capable of producing high-resolution, three-dimensional images of abnormalities of tissue growth inside the body but, it can also detect the type of abnormalities and their location using multispectral imaging techniques. It is possible to provide a portable, non-invasive device that is handheld and with which women may use to screen themselves for early detection of breast cancer without the need to visit a physician. As the present invention uses broadband sources and / or multiple coherent sources, secondary factors such as oxygen metabolism or blood volume associated with the cancer tissues could also be detected to provide further verification of the type. This invention would raise the accuracy of diagnosis and reduce the rate of false positives and false negatives.

Description

[0001]This application is a divisional of and claims the benefit of priority to co-owned U.S. patent application Ser. No. 14 / 984,717 of the same title filed Dec. 30, 2015 issuing as U.S. Pat. No. 10,357,162 on Jul. 23, 2019, the foregoing being incorporated herein by reference in its entirety.FIELD OF THE INVENTION[0002]This invention relates to detection of subcutaneous cellular mass utilizing optics and imaging techniques. More particularly, this invention is related to detecting (a) abnormal growth of tissues inside the body, (b) their types, (c) their dimensions, and (d) their location from outside the body (through non-invasive contact or non-contact with the body). More specifically, this invention is related to the means to detect abnormalities of tissue growth inside the body, their types, dimensions, and location from outside, more particularly the early diagnosis of the cancer, especially breast cancer. This invention also relates to a medical device that emits electromagn...

AI Technical Summary

Benefits of technology

Enables early detection of breast cancer through routine self-examination, reducing the rate of false positives and negatives, and offering a more sensitive, rapid, and cost-effective screening method.

Problems solved by technology

However, if the tumor is not detected until it has grown large and spread into the lymphatic system, chances of survival are greatly decreased.

Unfortunately, there is no device available that a woman may use to regularly screen herself for breast cancer at home.

It is not an effective preventive method because finding a lump likely indicates that the tumor has already been growing for years.

There is no evidence that routine examination reduces morality rates, and it is no longer a recommended screening method.

Such genetic screening does not detect the presence of breast cancer, but it may reveal a person's susceptibility to develop it.

Having a close relative diagnosed with breast cancer increases a woman's risk of breast cancer.

Moreover, since only a small percentage of breast cancer occurrences is caused by inheriting mutations, it is not a method that would be beneficial for the general public.

However, there is continued debate about whether this method is less helpful than it is helpful.

For example, one of the drawbacks is that false positives create long-lasting psychological stress and anxiety, which can affect the patient's wellness and behavior for many years.

On the other hand, false negatives estimated up to thirty percent occur, which can lead to missed opportunities for treatment if regular checking is not done.

Mammograms do not work well in younger women because their breast tissue is denser.

Cost can further be an issue, more so because insurance policies tend not to cover mammograms for women under forty, even though women in their teens or twenties are sometimes diagnosed with breast cancer.

Other drawbacks include discomfort and limitation in detection accuracy.

Patients undergoing mammograms have their breasts compressed, which can cause pain or discomfort.

Tumors sized smaller than one millimeter are difficult, if not impossible, to detect.

While it increases the detection rate of breast cancer, it also increases the rate of false positives.

However, it also produces greater false positives and is expensive, costing thousands of dollars.

It is a time-consuming and invasive procedure requiring injection of a contrast agent that poses a risk to patients with a history of renal disease.

Removing tissue from the breast can be a physically and psychologically challenging procedure.

Currently, this technique is not used for breast cancer screening and is typically only used for large-scale imaging of the entire body to determine if the cancer has spread from the breast area.

In addition, this technique is not non-invasive because it requires the injection of the dye as well as a visit to the physician.

While the use of light in the NIR range has the advantage of being highly sensitive and specific (can also reach deep tissue), it has the same problems as CAT scans in that it requires the injection of a drug and cannot be performed without the aid of a physician.

However, this technology is limited by the difficulty in distinguishing between absorption and scattering in tissue, as well as the need to rely on secondary factors (oxygen metabolism and blood volume) to determine the presence of a tumor.

Nevertheless, it can be seen that current methods of breast cancer screening and diagnostic methods can be stress inducing, unreliable, bulky, invasive, and costly.

Moreover, some women may also feel a stigma associated with breast cancer, and going through medical procedures related to breast cancer can make them feel especially vulnerable to privacy issues.

Images